Stephens Consulting’s Boston Scientific BSX Stock Holding History

Stephens Consulting’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$12.1K	Buy	+127	New	+$12.5K	﹤0.01%	229
2025 Q3	–	Sell	-40	Closed	-$4.3K	–	507
2025 Q2	$4.3K	Buy	+40	New	+$4.05K	﹤0.01%	404
2022 Q1	–	Sell	-39	Closed	-$1.66K	–	576
2021 Q4	$1.66K	Buy	+39	New	+$1.64K	﹤0.01%	633

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Stephens Consulting's BSX Position: Q4 2025 in Review

Stephens Consulting opened a new position in Boston Scientific (BSX) in Q4 2025: 127 shares worth $12.1K. The stake represents ﹤0.01% of the portfolio and ranks #229 among its holdings. This is a return to the name: Stephens Consulting previously reported a position in BSX as recently as Q2 2025.

Stephens Consulting first reported a position in BSX in Q4 2021 and has held it in 3 quarters since. 1,791 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Stephens Consulting held 127 shares of Boston Scientific worth $12.1K as of Q4 2025.
Boston Scientific was a new Stephens Consulting position in Q4 2025.
Boston Scientific made up ﹤0.01% of Stephens Consulting's portfolio in Q4 2025, its #229 holding.
Stephens Consulting first reported a position in Boston Scientific in Q4 2021 and has held it in 3 quarters since.
1,791 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.